General
Preferred name
TILUDRONIC ACID
Synonyms
Tiludronic Acid disodium ()
Tiludronic acid disodium salt ()
Tiludronate (disodium) ()
TILUDRONATE DISODIUM ()
Tiludronic acid (disodium) ()
SR-41319 ()
Skelid ()
tiludronate ()
SR 41319 ()
Acide tiludronique ()
Acido tiludronico ()
Tiludronate disodium anhydrous ()
SR 41319B ()
Tiludronate sodium ()
SR-41319B ()
Tiludronate (sodium salt) ()
P&D ID
PD009787
CAS
89987-06-4
149845-07-8
Tags
available
drug
Approved by
FDA
First approval
1997
Drug Status
withdrawn
approved
vet_approved
Max Phase
4.0
Drug indication
Bone disease
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Tiludronic acid belongs to the same non-nitrogenous bisphosphonate drug family as and clodronic acid (PubChem CID 25419). Marketed formulations contain tiludronate disodium (PubChem CID 60936).
(GtoPdb)
PRICE
92
DESCRIPTION
The disodium salt form of Tiludronic acid which has been found to be a biphosphonate bone resorption inhibitor and could be used against osteitis deformans.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Tiludronate disodium (Tiludronic acid disodium) is an osteoclast vacuolar H(+)-ATPase inhibitor with antiresorptive and anti-inflammatory properties. Tiludronate disodium can be used in studies about metabolic bone disorders.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
16
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
65
Molecular Weight
317.93
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
4
Rotatable Bonds
4
Ring Count
1
Aromatic Ring Count
1
cLogP
2.07
TPSA
115.06
Fraction CSP3
0.14
Chiral centers
0.0
Largest ring
6.0
QED
0.5
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Vacuolar type H+-ATPase
ATP6V1A, MMP2, PTPN1
Proton Pump
Indication
navicular syndrome
MOA
bone resorption inhibitor, osteoclast inhibitor
Pathway
Membrane Transporter/Ion Channel
Source data

